Lyell
lyell.com
Actively hiring
Oncology Therapeutics
Cell & Gene Therapy
Health Care
As featured in
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
51-200
employees, estimated range
Hiring now
8
+2 posted in 30 days
Backers
2
Foresite Capital, venBio Partners
Momentum
10/100
hiring for its size
Last sign of life
this month
a posting or a news item
Backed byfrom the funds' portfolios and accelerator catalogs
Foresite Capital 
venBio Partners Similar startupsby what they do, their industry and backers
BrainChild Bio is a kids-first, clinical-stage biotechnology company harnessing the power of CAR-T cell technology for tumors in the…
Autolus is a CAR T cell therapy company which develops advanced autologous T cell therapies that have the potential to deliver…
Generate the optimized scFvs to yield CAR-T cells with robust anti-tumor effect.
Umoja Biopharma pioneering immunotherapy by reprogramming T cells in vivo to target cancer cells and generate lasting remission.
The Next Generation in. OncoSenX is a late stage pre-clinical cancer company headquartered in Seattle, Washington. OncoSenX targets solid…
CAR T therapies with more durable responses, improving treatment outcomes and saving the lives of patients with refractory cancers.
News
Lyell Immunopharma To Participate in the Baird 2026 Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell therapies for patients with cancer, today
Read more
Report
Lyell Immunopharma Completes Manufacturing Transfer for LYL273 and Provides Updated Timeline on Phase 1/2 Trial in Metastatic Colorectal Cancer
Technology transfer to LyFE Manufacturing Center completed following FDA review of improved manufacturing process and updated analytical methodsD...
Read more
Report
Lyell Immunopharma: Ronde-Cel Manufacturing Success Reaches 97% As Safety Data Supports Outpatient CAR-T
Lyell Immunopharma reported a 97% manufacturing success rate for its ronde-cel CAR-T therapy as safety data from more than 100 lymphoma patients supported the potential for treatment to be administered in an outpatient setting.
Read more
Report
Lyell Immunopharma Presents Updated Safety Data and Translational Insights for Rondecabtagene Autoleucel (Ronde-Cel) in Patients with Large B-Cell Lymphoma at European Hematology Association 2026 Congress
Detailed price information for Lyell Immunopharma Inc (LYEL-Q) from The Globe and Mail including charting and trades.
Read more
Report
Publishing exec, abuse survivor Jen Lyell remembered as Southern Baptist Convention meets
Jennifer Lyell uplifted others' stories in her Christian publishing career, and then her own story faced attacks. Her triumphs are being remembered.
Read more
Report
Pro access
Upgrade to see all 11 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Tech stack
Technologies named in job postings at Lyell over the last 12 months, by layer, with the share of postings for each.
Technologies in use
2
Postings analysed
2
Stack modernity
79/100AI adopter
Cloud & platforms
GCP
AI & ML
Claude
Sign in to see how your skills match this stack
Sign In
Salary insights
Compensation ranges based on this company's open jobs
Median
$250k
Typical range
$185k – $300k
Open positions
8
8
Jobs
Senior
25%
Principal
12.5%
Architect
62.5%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Senior | 2 | $246k | $192k – $300k |
| Principal | 1 | $185k | $185k |
| Architect | 5 | $260k | $210k – $280k |
Highest paying role
Director or Senior Director, Investor Relations and Corporate Communications
$300k
Normalized to USD per year
Growth
Hiring Momentum
28/100
Slowing
Open positions
8
0 opened / 0 closed in 30 days
ATS activity
Every ~14 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Early Careers
63% ▼
Finance
25% ▲
Public Policy
13% ▲
Offices
Where the company hires and what each office is for
Cities
5
Hiring now
3
Countries
1
Busiest office
South San Francisco
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
South San Francisco
United States
HQ
South San Francisco
2 open roles 2 posted in 90 days 10-50 est. staff $255k Avg Salary
hires for Finance
201 Haskins Way, Suite 101,, South San Francisco, CA 94080
Bothell
United States
Regional office
Bothell
2 open roles 1 posted in 90 days 50% engineering 10-50 est. staff $168k Avg Salary
hires for QA, Early Careers
Seattle
United States
Regional office
Seattle
1 open roles 1 posted in 90 days 10-50 est. staff $192k Avg Salary
hires for Early Careers
Oregon
United States
Regional office
Oregon
West Hills
United States
Regional office
West Hills